Excessive carotid in-stent neointimal formation predicts late cardiovascular events

Journal of Endovascular Therapy

Volumn 11, Issue 3, 2004, Pages 229-239

  Schillinger, Martin ^a   Exner, Markus ^b   Sabeti, Schila ^a   Amighi, Jasmin ^a   Wagner, Oswald ^b   Ahmadi, Ramazanali ^a   Minar, Erich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Internal carotid artery; Mortality; Myocardial infarction; Neointimal hyperplasia; Outcome analysis; Restenosis; Stenosis; Stents; Stroke

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTERY DIAMETER; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY FLOW; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; DEATH; ECHOGRAPHY; EXCESSIVE CAROTID IN STENT NEOINTIMA FORMATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INFLAMMATION; INTERNAL CAROTID ARTERY; MAJOR ADVERSE CARDIOVASCULAR EVENT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; RESTENOSIS; STENT; STROKE; SURVIVAL;

AGED; C-REACTIVE PROTEIN; CAROTID STENOSIS; CAUSE OF DEATH; CEREBRAL INFARCTION; FEMALE; FIBROMUSCULAR DYSPLASIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; RECURRENCE; RISK; STENTS; SURVIVAL ANALYSIS; TUNICA INTIMA; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 3042653360     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/04-1214.1     Document Type: Article

References (34)

1. Yadav JS. The SAPPHIRE trial 1-year results. Transcatheter Cardiovascular Therapeutics; September 15-19, 2003; Washington, DC.
2. Ahmadi R, Willfort A, Lang W, et al. Carotid artery stenting: effect of learning curve and intermediate-term morphological outcome. J Endovasc Ther. 2001;8:539-546.
3. Ahmadi R, Schillinger M, Lang W, et al. Carotid artery stenting in older patients: is age a risk factor for poor outcome? J Endovasc Ther. 2002;9:559-565.
4. Schillinger M, Exner M, Mlekusch W, et al. Acute phase response after carotid stenting: association with 6 months in-stent restenosis. Radiology. 2003;227:516-521.
5. Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation. 2001;103:532-537.
6. Dietz A, Berkefeld J, Theron JG, et al. Endovascular treatment of symptomatic carotid stenosis using stent placement: long-term followup of patients with a balanced surgical risk/benefit ratio. Stroke. 2001;32:1855-1859.
7. Wholey MH, Wholey M, Mathias K, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv. 2000;50:160-167.
8. Willfort-Ehringer A, Ahmadi R, Gschwandtner ME, et al. Single-center experience with carotid stent restenosis. J Endovasc Ther. 2002;9:299-307.
9. Willfort-Ehringer A, Ahmadi R, Gschwandtner ME, et al. Healing of carotid stents: a prospective duplex ultrasound study. J Endovasc Ther. 2003;10:636-642.
10. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99:44-52.
11. Schillinger M, Exner M, Mlekusch W, et al. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. J Endovasc Ther. 2002;9:59-66.
12. Schillinger M, Exner M, Mlekusch W, et al. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Radiology. 2002;224:529-535.
13. Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology. 2002;225:21-26.
14. Schillinger M, Exner M, Amighi J, et al. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events in patients with advanced atherosclerosis. Circulation. 2003;108:2328-2328.
15. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation. 2003;107:391-397.
16. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
17. Albert CM, Ma J, Rifai N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002;105:2595-2599.
18. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
19. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
20. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329-1339.
21. De Bray JM, Glatt B. Quantification of atheromatous stenosis in the extracranial internal carotid artery. Cerebrovasc Dis. 1995;5:414-426.
22. Nicolaides AN, Shifrin EG, Bradbury A, et al. Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion? J Endovasc Surg. 1996;3:158-165.
23. Robbin ML, Lockhart ME, Weber TM, et al. Carotid artery stents: early and intermediate follow-up with Doppler US. Radiology. 1997;205:749-756.
24. Sabeti S, Schillinger M, Mlekusch W, et al. Duplex sonography for quantification of internal carotid artery stenosis-a comparative analysis of different flow velocity thresholds. Radiology. 2004 (in press)
25. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD) TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
26. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
27. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361:107-116.
28. Ferguson GG, Eliasziw M, Barr HW, et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke. 1999;30:1751-1758.
29. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001;357:1729-1737.
30. Forrester JS, Fishbein M, Helfant R, et al. A paradigm for restenosis based on cell biological clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17:758-769.
31. Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31:224-230.
32. Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107:1783-1790.
33. Castriota F, Cremonesi A, Manetti R, et al. Impact of cerebral protection devices on early outcome of carotid stenting. J Endovasc Ther. 2002;9:786-792.
34. Macdonald S, McKevitt F, Venables GS, et al. Neurological outcomes after carotid stenting protected with the NeuroShield Filter compared to unprotected stenting. J Endovasc Ther. 2002;9:777-785.